MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20253144

January 14, 2025

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g(按C₁₆H₂₈N₂O₄计)

化学药品

January 14, 2025

Company Information

Applicant Company

广东省东莞市松山湖园区畅园路2号

Manufacturing Company

北辰科技园区华实道88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath